Alnylam: CEO pay
Alnylam reported $14.9m in total pay for Yvonne L. Greenstreet, M.D. for the year ending 31 Dec 2025, and $77.4m in compensation actually paid. Its other named executives averaged $6.6m.
Yvonne L. Greenstreet, M.D., year ending 31 Dec 2025
$14.9mreported total
$77.4mcompensation actually paid
$6.6mother named executives, average total
$306what $100 invested at the start of the table became
Five years
| Year | CEO | Granted (reported total) | Compensation actually paid | Other executives, average | $100 invested became |
|---|---|---|---|---|---|
| 2025 | Yvonne L. Greenstreet, M.D. | $14.9m | $77.4m | $6.6m | $306 |
| 2024 | Yvonne L. Greenstreet, M.D. | $11.5m | $29.8m | $3.0m | $181 |
| 2023 | Yvonne L. Greenstreet, M.D. | $8.9m | $11.4m | $2.9m | $147 |
| 2022 | Yvonne L. Greenstreet, M.D. | $4.6m | $19.0m | $3.6m | $183 |
| 2021 | John M. Maraganore, Ph.D. | $10.2m | $17.5m | $5.9m | $130 |
Source: Alnylam's proxy statement, filed 6 Apr 2026. Only the CEO is reported individually in this data; the other named executives appear as an average.
Alnylam's jobs and advertised payFigures are as each company tagged them in its annual proxy statement filed with the US Securities and Exchange Commission, unadjusted. The reported total counts LTIP awards at their value on the day they were granted; compensation actually paid revalues them at what they became worth, so it can be far higher, or negative. How it works.